Medicare Procedure and Patient Information
Conditions of Medicare patients treated by Dr. Mathew R. Meeneghan, MD in 2014
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2014 were hypertension.
73 | |
(No ratings)
Dr. Mathew R. Meeneghan, MD is a medical oncologist in Bastrop, TX specializing in medical oncology, adult oncology and adult hematology. He graduated from University of Virginia School of Medicine. Dr. Mathew R. Meeneghan, MD is affiliated with CHRISTUS Health, AdventHealth (CO, FL, GA, IL, KS, KY, NC, TX, and WI), Texas Oncology, Ascension Health and Advent Health.
3107 Highway 71 East
Bastrop, TX 78602
4101 James Casey Street Suite 100
Austin, TX 78745
901 W 38th Street Suite 200
Austin, TX 78705
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2014 were hypertension.
Hypertension | 73 |
---|---|
High Cholesterol | 0 |
Stroke | 0 |
Ischemic Heart Disease | 0 |
Depression | 0 |
Chronic Kidney Disease | 0 |
Asthma | 0 |
Osteoperosis | 0 |
Atrial Fibrilation | 0 |
Heart Failure | 0 |
Chronic Obstructive Pulmonary Disease | 0 |
Diabetes | 0 |
Dementia | 0 |
Cancer | 0 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2015 were lab tests, blood draw, and .
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
blood draw | 103 |
---|---|
doctor visit | 156 |
lab tests | 153 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 72 |
---|---|
Female | 110 |
Non-Hispanic White | 156 |
---|---|
Black | 0 |
Hispanic | 0 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 92 |
---|---|
From 75 to 84 | 44 |
85 and over | 0 |
Less than 65 | 0 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2015 were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.
Hypertension | 69 |
---|---|
High Cholesterol | 57 |
Stroke | 0 |
Ischemic Heart Disease | 40 |
Depression | 30 |
Chronic Kidney Disease | 36 |
Asthma | 21 |
Osteoperosis | 0 |
Atrial Fibrilation | 14 |
Heart Failure | 25 |
Chronic Obstructive Pulmonary Disease | 19 |
Diabetes | 34 |
Dementia | 18 |
Cancer | 33 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2016 were lab tests, blood draw, minimally invasive procedures and inpatient care.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
aspiration | 13 |
---|---|
biological response modifier (BRM) therapy | 199 |
blood draw | 696 |
bone marrow tests | 29 |
chemotherapy | 199 |
diagnostic procedures | 29 |
doctor visit | 807 |
hospital care | 255 |
inpatient care | 255 |
lab tests | 1607 |
minimally invasive procedures | 326 |
port flush | 61 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 220 |
---|---|
Female | 202 |
Non-Hispanic White | 344 |
---|---|
Black | 0 |
Hispanic | 43 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 184 |
---|---|
From 75 to 84 | 126 |
85 and over | 63 |
Less than 65 | 49 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2016 were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.
Hypertension | 72 |
---|---|
High Cholesterol | 56 |
Stroke | 7 |
Ischemic Heart Disease | 46 |
Depression | 28 |
Chronic Kidney Disease | 44 |
Asthma | 25 |
Osteoperosis | 8 |
Atrial Fibrilation | 17 |
Heart Failure | 28 |
Chronic Obstructive Pulmonary Disease | 22 |
Diabetes | 34 |
Dementia | 14 |
Cancer | 37 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2017 were lab tests, blood draw, minimally invasive procedures and inpatient care.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
aspiration | 18 |
---|---|
biological response modifier (BRM) therapy | 234 |
blood draw | 882 |
bone marrow tests | 36 |
chemotherapy | 234 |
diagnostic procedures | 36 |
doctor visit | 1220 |
hormone therapy | 11 |
hospital care | 313 |
inpatient care | 313 |
lab tests | 3291 |
minimally invasive procedures | 400 |
port flush | 98 |
thyroid function tests | 33 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 280 |
---|---|
Female | 308 |
Non-Hispanic White | 474 |
---|---|
Black | 43 |
Hispanic | 57 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 258 |
---|---|
From 75 to 84 | 190 |
85 and over | 79 |
Less than 65 | 61 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2017 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 73 |
---|---|
High Cholesterol | 55 |
Stroke | 9 |
Ischemic Heart Disease | 46 |
Depression | 31 |
Chronic Kidney Disease | 46 |
Asthma | 9 |
Osteoperosis | 9 |
Atrial Fibrilation | 18 |
Heart Failure | 27 |
Chronic Obstructive Pulmonary Disease | 22 |
Diabetes | 35 |
Dementia | 16 |
Cancer | 37 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2018 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
abdominal imaging | 21 |
---|---|
biological response modifier (BRM) therapy | 290 |
blood draw | 1060 |
chemotherapy | 290 |
CT scan | 46 |
doctor visit | 1377 |
hormone therapy | 42 |
hospital care | 283 |
inpatient care | 283 |
lab tests | 4214 |
minimally invasive procedures | 414 |
pelvic imaging | 21 |
port flush | 99 |
thoracic (chest) imaging | 25 |
thyroid function tests | 55 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 313 |
---|---|
Female | 361 |
Non-Hispanic White | 532 |
---|---|
Black | 42 |
Hispanic | 79 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 313 |
---|---|
From 75 to 84 | 217 |
85 and over | 85 |
Less than 65 | 59 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2018 were hypertension, high cholesterol, cancer and chronic kidney disease.
Hypertension | 72 |
---|---|
High Cholesterol | 55 |
Stroke | 7 |
Ischemic Heart Disease | 42 |
Depression | 25 |
Chronic Kidney Disease | 43 |
Asthma | 8 |
Osteoperosis | 10 |
Atrial Fibrilation | 16 |
Heart Failure | 25 |
Chronic Obstructive Pulmonary Disease | 20 |
Diabetes | 33 |
Dementia | 16 |
Cancer | 43 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2019 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 368 |
---|---|
blood draw | 1388 |
chemotherapy | 368 |
CT scan | 10 |
doctor visit | 1340 |
hormone therapy | 39 |
hospital care | 285 |
inpatient care | 285 |
lab tests | 5171 |
minimally invasive procedures | 566 |
port flush | 103 |
thoracic (chest) imaging | 11 |
thyroid function tests | 41 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 351 |
---|---|
Female | 399 |
Non-Hispanic White | 607 |
---|---|
Black | 47 |
Hispanic | 76 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 340 |
---|---|
From 75 to 84 | 252 |
85 and over | 95 |
Less than 65 | 63 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2019 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 72 |
---|---|
High Cholesterol | 58 |
Stroke | 6 |
Ischemic Heart Disease | 43 |
Depression | 29 |
Chronic Kidney Disease | 44 |
Asthma | 8 |
Osteoperosis | 10 |
Atrial Fibrilation | 17 |
Heart Failure | 27 |
Chronic Obstructive Pulmonary Disease | 20 |
Diabetes | 33 |
Dementia | 17 |
Cancer | 41 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2020 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 373 |
---|---|
blood draw | 1395 |
chemotherapy | 373 |
doctor visit | 1375 |
hormone therapy | 46 |
hospital care | 308 |
inpatient care | 308 |
lab tests | 5504 |
minimally invasive procedures | 553 |
port flush | 61 |
thyroid function tests | 29 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 327 |
---|---|
Female | 406 |
Non-Hispanic White | 582 |
---|---|
Black | 47 |
Hispanic | 86 |
Asian | 0 |
Other | 0 |
Native American | 0 |
From 65 to 74 | 356 |
---|---|
From 75 to 84 | 244 |
85 and over | 89 |
Less than 65 | 44 |
The most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated during 2020 were hypertension, high cholesterol, chronic kidney disease and ischemic heart disease.
Hypertension | 70 |
---|---|
High Cholesterol | 58 |
Stroke | 7 |
Ischemic Heart Disease | 44 |
Depression | 29 |
Chronic Kidney Disease | 44 |
Asthma | 7 |
Osteoperosis | 11 |
Atrial Fibrilation | 16 |
Heart Failure | 26 |
Chronic Obstructive Pulmonary Disease | 15 |
Diabetes | 32 |
Dementia | 17 |
Cancer | 42 |
The top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX during 2021 were lab tests, blood draw, minimally invasive procedures and chemotherapy.
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
biological response modifier (BRM) therapy | 354 |
---|---|
blood draw | 1224 |
chemotherapy | 354 |
doctor visit | 1116 |
hormone therapy | 33 |
hospital care | 275 |
inpatient care | 275 |
lab tests | 5312 |
minimally invasive procedures | 493 |
port flush | 23 |
thyroid function tests | 36 |
Volume of procedures performed by Dr. Mathew R. Meeneghan, MD for Medicare patients.
The highest averages for the top procedures that Dr. Mathew R. Meeneghan, MD treated as a medical oncologist in Bastrop, TX were lab tests, blood draw, minimally invasive procedures and chemotherapy.
abdominal imaging | 21 |
---|---|
aspiration | 15 |
biological response modifier (BRM) therapy | 303 |
blood draw | 964 |
bone marrow tests | 32 |
chemotherapy | 303 |
CT scan | 28 |
diagnostic procedures | 32 |
doctor visit | 1057 |
hormone therapy | 34 |
hospital care | 286 |
inpatient care | 286 |
lab tests | 3614 |
minimally invasive procedures | 458 |
pelvic imaging | 21 |
thoracic (chest) imaging | 18 |
thyroid function tests | 38 |
Information about Medicare patients treated by Dr. Mathew R. Meeneghan, MD.
Male | 173 |
---|---|
Female | 198 |
Black / African American | 19 |
---|---|
Asian / Pacific Islander | 0 |
Non-Hispanic White | 299 |
Hispanic | 37 |
Native American / Alaskan Native | 0 |
Other | 0 |
85 and over | 45 |
---|---|
75 to 84 | 119 |
Less than 65 | 30 |
65 to 74 | 171 |
The highest averages of the most common conditions of Medicare patients that Dr. Mathew R. Meeneghan, MD treated were hypertension, high cholesterol, ischemic heart disease and chronic kidney disease.
Hypertension | 55 |
---|---|
High Cholesterol | 37 |
Stroke | 4 |
Ischemic Heart Disease | 29 |
Depression | 19 |
Chronic Kidney Disease | 28 |
Asthma | 8 |
Osteoporosis | 5 |
Heart Failure | 17 |
Chronic Obstructive Pulmonary Disease | 13 |
Diabetes | 22 |
Atrial Fibrillation | 10 |
Cancer | 25 |
Dementia | 10 |
Dr. Mathew R. Meeneghan, MD graduated from University of Virginia School of Medicine. He completed residency at Vanderbilt University Medical Center. He is certified by the Internal Medicine: The American Board of Internal Medicine and has a state license in North Carolina.
Medical School: University of Virginia School of Medicine
Residency: Vanderbilt University Medical Center
Board Certification: Internal Medicine: The American Board of Internal Medicine
Licensed In: North Carolina
Dr. Mathew R. Meeneghan, MD is associated with these hospitals and organizations:
Dr. Mathew R. Meeneghan, MD does not have any reviews yet, be the first to leave a review of Dr. Mathew R. Meeneghan, MD here: Leave a Review
(No ratings)
These charts describe general payments received by Dr. Mathew R. Meeneghan, MD. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.
Alexion Pharmaceuticals, Inc. |
$150
ULTOMIRIS $150 |
||||
---|---|---|---|---|---|
Genentech USA, Inc. |
$134
Venclexta $123 |
Cotellic $10 |
|||
Pharmacyclics LLC, An AbbVie Company |
$123
IMBRUVICA $123 |
||||
Jazz Pharmaceuticals Inc. |
$122
VYXEOS $122 |
||||
Millennium Pharmaceuticals, Inc. |
$110
NINLARO $110 |
||||
Other |
$136
IMBRUVICA $36 |
TASIGNA $26 |
OPDIVO $23 |
Gilotrif $15 |
$36 |
Food and Beverage | $588 |
---|---|
Honoraria | $150 |
Education | $36 |
Dr. Mathew Meeneghan is a physician who specializes in adult hematology, adult oncology, and medical oncology. After completing medical school at the University of Virginia School of Medicine, he performed his residency at Vanderbilt University Medical Center. Dr. Meeneghan is professionally affiliated with AdventHealth (CO, FL, GA, IL, KS, KY, NC, TX, and WI), Ascension Health, and Texas Oncology. AdventHealth reports that he is accepting new patients at his office in Austin, TX.